CN Patent

CN104487056A — 包含肽和递送剂的片剂制剂

Assigned to Novo Nordisk AS · Expires 2015-04-01 · 11y expired

What this patent protects

本发明涉及包含GLP-1肽和递送剂(诸如SNAC)的固体组合物及其用途。

USPTO Abstract

本发明涉及包含GLP-1肽和递送剂(诸如SNAC)的固体组合物及其用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN104487056A
Jurisdiction
CN
Classification
—
Expires
2015-04-01
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.